1 |
35089437 |
10.1007/s00018-022-04139-y |
2022 |
A20 undermines alternative NF-κB activity and expression of anti-apoptotic genes in Helicobacter pylori infection. |
NFKB1 |
2 |
36009586 |
10.3390/biomedicines10082038 |
2022 |
Genomic Aberrations Generate Fusion Gene FOXK2::TP63 and Activate NFKB1 in Cutaneous T-Cell Lymphoma. |
NFKB1 |
3 |
30887112 |
10.1007/s00109-019-01777-x |
2019 |
Activation of NF-κB in B cell receptor signaling through Bruton's tyrosine kinase-dependent phosphorylation of IκB-α. |
NFKB1 |
4 |
29593668 |
10.3389/fmicb.2018.00380 |
2018 |
Simulation Study of cDNA Dataset to Investigate Possible Association of Differentially Expressed Genes of Human THP1-Monocytic Cells in Cancer Progression Affected by Bacterial Shiga Toxins. |
NFKB1 |
5 |
27840321 |
10.1016/j.freeradbiomed.2016.11.010 |
2017 |
Pro-apoptotic effects of lipid oxidation products: HNE at the crossroads of NF-κB pathway and anti-apoptotic Bcl-2. |
NFKB1 |
6 |
28281555 |
10.1038/modpathol.2017.5 |
2017 |
NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53. |
NFKB1 |
7 |
28368397 |
10.1038/onc.2017.90 |
2017 |
Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype. |
NFKB1 |
8 |
28672935 |
10.3892/etm.2017.4464 |
2017 |
Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer. |
NFKB1 |
9 |
26767426 |
10.1016/j.jid.2015.12.027 |
2016 |
MALT1 Protease Activity Controls the Expression of Inflammatory Genes in Keratinocytes upon Zymosan Stimulation. |
NFKB1 |
10 |
26776161 |
10.1038/onc.2015.493 |
2016 |
Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. |
NFKB1 |
11 |
26792751 |
10.1128/JVI.03000-15 |
2016 |
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein. |
NFKB1 |
12 |
27262792 |
10.1016/j.semcancer.2016.05.002 |
2016 |
Mechanisms of NF-κB deregulation in lymphoid malignancies. |
NFKB1 |
13 |
27452667 |
10.1016/j.semcancer.2016.07.003 |
2016 |
MALT lymphoma: A paradigm of NF-κB dysregulation. |
NFKB1 |
14 |
25960206 |
10.1002/gcc.22253 |
2015 |
NFkB is activated by multiple mechanisms in hairy cell leukemia. |
NFKB1 |
15 |
25996250 |
10.1111/febs.13325 |
2015 |
MALT1--a universal soldier: multiple strategies to ensure NF-κB activation and target gene expression. |
NFKB1 |
16 |
26487345 |
10.1038/srep15215 |
2015 |
Transcription factor and miRNA co-regulatory network reveals shared and specific regulators in the development of B cell and T cell. |
NFKB1 |
17 |
26668357 |
10.1073/pnas.1507459112 |
2015 |
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation. |
NFKB1 |
18 |
24200242 |
10.1089/scd.2013.0270 |
2014 |
Resistance of hematopoietic progenitors to Fas-mediated apoptosis is actively sustained by NFκB with a characteristic transcriptional signature. |
NFKB1 |
19 |
24704296 |
10.1016/j.canlet.2014.03.030 |
2014 |
The NF-κB inhibitor DHMEQ decreases survival factors, overcomes the protective activity of microenvironment and synergizes with chemotherapy agents in classical Hodgkin lymphoma. |
NFKB1 |
20 |
19897484 |
10.1074/jbc.M109.050815 |
2010 |
B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation. |
NFKB1 |
21 |
19412164 |
10.1038/nature07968 |
2009 |
Mutations of multiple genes cause deregulation of NF-kappaB in diffuse large B-cell lymphoma. |
NFKB1 |
22 |
19573080 |
10.1111/j.1365-2141.2009.07790.x |
2009 |
Common genetic variants in candidate genes and risk of familial lymphoid malignancies. |
NFKB1 |
23 |
19709433 |
10.1186/1476-4598-8-67 |
2009 |
STAT5 regulation of BCL10 parallels constitutive NFkappaB activation in lymphoid tumor cells. |
NFKB1 |
24 |
19773279 |
10.1136/oem.2008.044024 |
2009 |
Association between genetic variants in VEGF, ERCC3 and occupational benzene haematotoxicity. |
NFKB1 |
25 |
18252714 |
10.1074/jbc.M708833200 |
2008 |
Toll-like receptor 4 mediates induction of the Bcl10-NFkappaB-interleukin-8 inflammatory pathway by carrageenan in human intestinal epithelial cells. |
NFKB1 |
26 |
18636124 |
10.1371/journal.pone.0002816 |
2008 |
Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. |
NFKB1 |
27 |
17356384 |
10.1097/01.jnen.0000248553.45456.96 |
2007 |
Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression. |
NFKB1 |
28 |
17502353 |
10.1128/MCB.01645-06 |
2007 |
Phosphorylation of Bcl10 negatively regulates T-cell receptor-mediated NF-kappaB activation. |
NFKB1 |
29 |
15231650 |
10.1158/0008-5472.CAN-03-3885 |
2004 |
High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas. |
NFKB1 |
30 |
15514680 |
10.1038/sj.embor.7400280 |
2004 |
Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds. |
NFKB1 |
31 |
12032828 |
10.1038/sj.onc.1205483 |
2002 |
NF-kappaB activates Bcl-2 expression in t(14;18) lymphoma cells. |
NFKB1 |